Inozyme Pharma
Di Chu, Ph.D. has a diverse background in research and academia. With experience in studying glycoproteins in lysosomes, characterizing gene expression, and researching cell fate change using stem cells, Di currently works at Inozyme Pharma as a Senior Scientist. Di's expertise includes in-vitro assays, protein characterization, and epigenetics research. With a Master's degree in Biotechnology from Northwestern University, Di has a strong foundation in molecular genetics and bioprocessing.
Inozyme Pharma
Inozyme Pharma is a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases.